z-logo
Premium
Effects of oral vaccination against vibriosis in turbot, Scophthalmus maximus (L.), and sea bass, Dicentrarchus labrax (L.)
Author(s) -
DEC C.,
ANGELIDIS P.,
LAURENCIN F. BAUDIN
Publication year - 1990
Publication title -
journal of fish diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 85
eISSN - 1365-2761
pISSN - 0140-7775
DOI - 10.1111/j.1365-2761.1990.tb00795.x
Subject(s) - turbot , sea bass , dicentrarchus , vibrio anguillarum , biology , scophthalmus , vaccination , fishery , inoculation , microbiology and biotechnology , intraperitoneal injection , veterinary medicine , immunology , vibrio , fish <actinopterygii> , medicine , bacteria , genetics , pharmacology
. Turbot, Scophthalmus maximus (L.), and sea bass, Dicentrarchus labrax (L.), are susceptible to vibriosis, a septicaemia caused in France by Vibrio anguillarum 408. A bacterin produced with this strain by Rhône–Merieux has been tested orally in both species and, as a comparison, by intraperitoneal injection. During a challenge carried out 4 weeks later by intraperitoneal inoculation, the protection observed in orally vaccinated fishes was significant (72 % in sea bass and 70 % in turbot). Eleven weeks after vaccination, this protection is still significant. The mean titre of serum agglutinins was weakly increased in orally vaccinated fishes. Bacteriostatic antibodies have also been searched for in serum, but compared to agglutination, the applied technique leads to lower titres and it has not been possible to prove the presence of such antibodies after oral vaccination. Passive immunizations using serum from orally vaccinated fishes (2 months after vaccination) confers some protection against a challenge carried out by inoculation of virulent vibrio. Therefore, the production of serum factors following oral vaccination of sea bass and turbot may be involved in generalized protection of fish.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here